R 3064 R 3064 (Amphetamine and dextroamphetamine extended release 25 mg)
Pill imprint R 3064 R 3064 has been identified as Amphetamine and dextroamphetamine extended release 25 mg.
Amphetamine/dextroamphetamine is used in the treatment of adhd; narcolepsy; fatigue and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Amphetamine/dextroamphetamine 25 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Images for R 3064 R 3064
- 25 mg
- Prescription only
- Drug Class:
- CNS stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Actavis Elizabeth LLC
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
methacrylic acid - methyl methacrylate copolymer (1:1)
methacrylic acid - methyl methacrylate copolymer (1:2)
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
More about amphetamine/dextroamphetamine
- Amphetamine/dextroamphetamine extended-release capsules
- Amphetamine and dextroamphetamine
- Amphetamine and dextroamphetamine (Advanced Reading)
- Dextroamphetamine and amphetamine (Advanced Reading)
- Amphetamine Sulfate (AHFS Monograph)
- Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate ER Capsules (FDA)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.